Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles
BACKGROUND: The hepatitis B virus core (HBc) particle is known as a promising new carrier for the delivery of drugs and nucleic acids. However, since the arginine-rich domain that is located in the C-terminal region of the HBc monomer binds to the heparan sulphate proteoglycan on the cell surface du...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Biomed Central
2015
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/57364/ http://irep.iium.edu.my/57364/ http://irep.iium.edu.my/57364/1/Suffian%20et%20al.%20Journal%20of%20Nanobiotechnology.pdf |
id |
iium-57364 |
---|---|
recordtype |
eprints |
spelling |
iium-573642017-06-23T00:04:31Z http://irep.iium.edu.my/57364/ Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles Mohamed Suffian, Izzat Fahimuddin Nishimura, Yuya Morita, Kenta Nakamura-Tsuruta, Sachiko Al-Jamal, Khuloud Ishii, Jun Ogino, Chiaki Kondo, Akihiko QH301 Biology QR355 Virology RM Therapeutics. Pharmacology BACKGROUND: The hepatitis B virus core (HBc) particle is known as a promising new carrier for the delivery of drugs and nucleic acids. However, since the arginine-rich domain that is located in the C-terminal region of the HBc monomer binds to the heparan sulphate proteoglycan on the cell surface due to its positive charge, HBc particles are introduced non-specifically into a wide range of cells. To avoid non-specific cellular uptake with the intent to control the ability of cell targeting, we individually replaced the respective arginine (R) residues of the arginine-rich domain located in amino acid positions 150-159 in glycine (G) residues. RESULTS: The mutated HBc particles in which R154 was replaced with glycine (G) residue (R154G) showed a drastic decrease in the ability to bind to the heparan sulphate proteoglycan and to avoid non-specific cellular uptake by several types of cancer cells. CONCLUSIONS: Because this mutant particle retains most of its C-terminal arginine-rich residues, it would be useful in the targeting of specificity-altered HBc particles in the delivery of nucleic acids. Biomed Central 2015-02-13 Article PeerReviewed application/pdf en http://irep.iium.edu.my/57364/1/Suffian%20et%20al.%20Journal%20of%20Nanobiotechnology.pdf Mohamed Suffian, Izzat Fahimuddin and Nishimura, Yuya and Morita, Kenta and Nakamura-Tsuruta, Sachiko and Al-Jamal, Khuloud and Ishii, Jun and Ogino, Chiaki and Kondo, Akihiko (2015) Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles. Nanobiotechnology, 13. ISSN 1477-3155 http://dx.doi.org/10.1186/s12951-015-0074-8 |
repository_type |
Digital Repository |
institution_category |
Local University |
institution |
International Islamic University Malaysia |
building |
IIUM Repository |
collection |
Online Access |
language |
English |
topic |
QH301 Biology QR355 Virology RM Therapeutics. Pharmacology |
spellingShingle |
QH301 Biology QR355 Virology RM Therapeutics. Pharmacology Mohamed Suffian, Izzat Fahimuddin Nishimura, Yuya Morita, Kenta Nakamura-Tsuruta, Sachiko Al-Jamal, Khuloud Ishii, Jun Ogino, Chiaki Kondo, Akihiko Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles |
description |
BACKGROUND: The hepatitis B virus core (HBc) particle is known as a promising new carrier for the delivery of drugs and nucleic acids. However, since the arginine-rich domain that is located in the C-terminal region of the HBc monomer binds to the heparan sulphate proteoglycan on the cell surface due to its positive charge, HBc particles are introduced non-specifically into a wide range of cells. To avoid non-specific cellular uptake with the intent to control the ability of cell targeting, we individually replaced the respective arginine (R) residues of the arginine-rich domain located in amino acid positions 150-159 in glycine (G) residues.
RESULTS: The mutated HBc particles in which R154 was replaced with glycine (G) residue (R154G) showed a drastic decrease in the ability to bind to the heparan sulphate proteoglycan and to avoid non-specific cellular uptake by several types of cancer cells.
CONCLUSIONS: Because this mutant particle retains most of its C-terminal arginine-rich residues, it would be useful in the targeting of specificity-altered HBc particles in the delivery of nucleic acids. |
format |
Article |
author |
Mohamed Suffian, Izzat Fahimuddin Nishimura, Yuya Morita, Kenta Nakamura-Tsuruta, Sachiko Al-Jamal, Khuloud Ishii, Jun Ogino, Chiaki Kondo, Akihiko |
author_facet |
Mohamed Suffian, Izzat Fahimuddin Nishimura, Yuya Morita, Kenta Nakamura-Tsuruta, Sachiko Al-Jamal, Khuloud Ishii, Jun Ogino, Chiaki Kondo, Akihiko |
author_sort |
Mohamed Suffian, Izzat Fahimuddin |
title |
Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles |
title_short |
Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles |
title_full |
Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles |
title_fullStr |
Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles |
title_full_unstemmed |
Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles |
title_sort |
mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis b virus core particles |
publisher |
Biomed Central |
publishDate |
2015 |
url |
http://irep.iium.edu.my/57364/ http://irep.iium.edu.my/57364/ http://irep.iium.edu.my/57364/1/Suffian%20et%20al.%20Journal%20of%20Nanobiotechnology.pdf |
first_indexed |
2023-09-18T21:21:05Z |
last_indexed |
2023-09-18T21:21:05Z |
_version_ |
1777411886523875328 |